K253148 is an FDA 510(k) clearance for the RX-1 Sleep. Classified as Ventilatory Effort Recorder (product code MNR), Class II - Special Controls.
Submitted by Vivaquant, Inc. Dba Rhythm Express (Arden Hills, US). The FDA issued a Cleared decision on June 22, 2026 after a review of 270 days - an extended review cycle.
This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2375 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.
View all Vivaquant, Inc. Dba Rhythm Express devices
NCT06907888
Completed
Observational
Industry-sponsored
Rhythm Express Wearable System vs. Simultaneous Polysomnography for the Diagnosis of Obstructive Sleep Apnea in Adults With Suspected or Observed Atrial Fibrillation
A Confirmatory Study to Evaluate the Rhythm Express Wearable System vs. Simultaneous Polysomnography (PSG) for the Diagnosis of Obstructive Sleep Apnea in an Adult Population With Observed or Suspected Atrial Fibrillation, and Are Indicated for Ambulatory Cardiac Monitoring
| Condition studied |
Obstructive Sleep Apnea (OSA); Atrial Fibrillation (Paroxysmal); Palpitations |
| Eligibility |
All sexes
· 21 Years+
|
| Principal investigator |
Brian Brockway |
| Sponsor |
VivaQuant
(industry)
|
Started 2024-11-18
→
Primary completion 2025-06-16
→
Completed 2025-06-25
Primary outcome
Sensitivity and Specificity (AHI>5)
Secondary outcome
Sensitivity and Specificity (AHI>15)
Study completed - no results published.
This trial concluded in 2025 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov